, Inc. ( OTC
), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has hired Mr. Ivan Klarich, who is an expert in managing the launching of "Go to Market" strategies for new product compliance. The Company wants to avoid the pitfalls often found in the launching a new product or product line. The Company wants to assure a solid strategy behind the launch for the labeling, marketing and distribution. The "Quality Control" plan will assure the product meets strict guidelines, starting with the manufacturer all the way through to the point of purchase. The Company plans to continue to hire several experts in the specialty pharmaceutical field as the Company rolls out an aggressive growth plan for 2017 and the years ahead."
Very excited for this PR
and what it means for the long run for VDRM
. Anyone who has been following my posts knows I'm very long long on this company in 2017.
I think we may see a 20% green day today, but even if we continue to go back down a bit I have no worries and will continuing buying more.
long and strong!
Millionaires will be made